News Cardiome antibiotic could reduce pressure on NHS Xydalba allows patients to be treated and quickly discharged.
News Novo Nordisk preps filings for sickle cell drug etavopivat Novo Nordisk has claimed a key win in its head-to-head race with Agios to bring an oral PKR activator to the market for sickle cell disease.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
